Document is current
Any future updates will be listed below
-
Authors
Greco, Raffaella https://orcid.org/0000-0002-6117-5328
Saccardi, Riccardo
Ponzano, Marta
Badoglio, Manuela https://orcid.org/0000-0003-3226-2024
Helbig, Grzegorz
Smilowski, Marek
Mariottini, Alice https://orcid.org/0000-0002-1869-7067
Burman, Joachim https://orcid.org/0000-0002-7045-1806
Carlson, Kristina
Kazmi, Majid https://orcid.org/0000-0002-6863-6297
Muraro, Paolo A. https://orcid.org/0000-0002-3822-1218
Gabriel, Ian
Withers, Barbara
Massey, Jennifer
Varaldo, Riccardo
Inglese, Matilde
Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Gil-Perotin, Sara
Sharrack, Basil
Roldan, Elisa https://orcid.org/0000-0001-7242-170X
Nozzoli, Chiara
Signori, Alessio
Sormani, Maria Pia
Alexander, Tobias https://orcid.org/0000-0003-1193-0097
Snowden, John A. https://orcid.org/0000-0001-6819-3476
- License Information
-
More Information
Article History
Received: 19 May 2025
Revised: 7 August 2025
Accepted: 5 September 2025
First Online: 29 September 2025
Competing interests
: AM discloses speaker honoraria for educational events from Biogen, Janssen, Merck, Novartis, Sandoz, Sanofi, Viatris. ER declares speaker honoraria from Janssen. JAS discloses honoraria for advisory boards from Vertex, Jazz, BMS and Medac. PAM declares consulting for Teva, Glenmark and Cellerys. RG declares speaker honoraria for educational events from Biotest, Pfizer, Medac, Qiagen, Kyverna MSD and Magenta and advisory board from Pfizer, BMS. TA declares study support from Janssen Cilag. The remaining authors have nothing to declare.
: This study and registry data analysis were approved, led and supported by the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Patients provided informed written consent for the inclusion of their non-identifiable data into the EBMT Registry. The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.
